Search Results - "Dallio, M."
-
1
Role of bisphenol A as environmental factor in the promotion of non‐alcoholic fatty liver disease: in vitro and clinical study
Published in Alimentary pharmacology & therapeutics (01-03-2018)“…Summary Background Bisphenol A is an endocrine disrupting chemical associated with type 2 diabetes mellitus (T2DM), cardiovascular disease and liver enzyme…”
Get full text
Journal Article -
2
The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction
Published in European review for medical and pharmacological sciences (01-11-2016)“…The non-alcoholic fatty liver disease is considered a predominant hepatopathy worldwide and a component of metabolic syndrome. It represents a risk factor for…”
Get more information
Journal Article -
3
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence
Published in Metabolomics (28-11-2022)“…Introduction Accumulating evidence have shown a significant correlation between urinary volatile organic compounds (VOCs) profile and the manifestation of…”
Get full text
Journal Article -
4
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report
Published in BMC gastroenterology (21-01-2021)“…Percutaneous Endoscopic Gastrostomy (PEG) can involve some complications, despite the good safety of its track record. The Buried Bumper Syndrome (BBS) is a…”
Get full text
Journal Article -
5
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender
Published in Journal of physiology and pharmacology : an official journal of the Polish Physiological Society (01-06-2015)“…Zeolites are microscopic minerals of volcanic origin, and the zeolite most commonly used in medicine is clinoptilolite. Over the years, clinoptilolite has been…”
Get more information
Journal Article -
6
-
7
-
8
P.08.8: Silybin in Combination with Regorafenib as a Novel Potential Strategy for the Treatment of Metastatic Colorectal Cancer Patients
Published in Digestive and liver disease (15-03-2017)Get full text
Journal Article -
9
-
10
-
11
-
12
P.01.4 ENDOCAN AS SERUM MARKER OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND/OR TYPE 2 DIABETES
Published in Digestive and liver disease (24-02-2016)Get full text
Journal Article -
13
Crohn’s disease and skin
Published in United European Gastroenterology Journal (01-04-2016)“…Crohn’s disease is a chronic inflammatory bowel disease potentially involving any segment of the gastrointestinal tract. Extra-intestinal manifestations may…”
Get full text
Book Review Journal Article -
14
P.18.6 FOOD INTAKE, GASTROINTESTINAL HORMONES AND INTESTINAL PERMEABILITY IN PATIENTS WITH HCV-RELATED CHRONIC LIVER DISEASE
Published in Digestive and liver disease (01-03-2013)Get full text
Journal Article -
15
-
16
P.17.17 SERUM CONCENTRATION OF 49 PROTEINS IN PATIENTS WITH CHRONIC GASTRITIS BY MULTIPLEX BIOMETRIC IMMUNOASSAY
Published in Digestive and liver disease (01-03-2014)Get full text
Journal Article -
17
P.14.5 THE ROLE OF HELICOBACTER PYLORI INFECTION AND SMALL INTESTINAL BACTERIAL OVERGROWTH IN ROSACEA
Published in Digestive and liver disease (01-03-2014)Get full text
Journal Article -
18
-
19
Steatosis in patients with HCV chronic liver disease: Baseline results from patients enrolled in the PITER cohort study
Published in Digestive and liver disease (07-10-2015)Get full text
Journal Article -
20
OC.03.3: CAN CHAT GENERATIVE PRE-TRAINED TRANSFORMER (CHATGPT) BE AN AI-PROVIDED FRIEND OF THE IBD PATIENTS FOR FREQUENTLY ASKED QUESTIONS RELATED TO THEIR DISEASE MANAGEMENT? AN EVIDENCE- AND GUIDELINESCONTROLLED TEXTUAL ANALYSIS OF AI-PROVIDED OUTPUTS
Published in Digestive and liver disease (01-04-2024)Get full text
Journal Article